Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Patients with severe chronic hand dermatitis, that has not responded to topical treatment,
including topical steroids and the avoidance of aggravating factors, will be treated with the
oral medication alitretinoin. The study aims to investigate the safety and efficacy of the
medication when given over a period of 6 months.